Tapewire

NYSE · USD

ELV

Elevance Health, Inc.

Export transactions ↓
Tapewire entity
2934
SEC CIK
0001156039
Parsed reports
385

Last 12 months

Inside the activity.

4 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202612
Apr 202600
May 202601
Jun 202602
Jul 202630
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2018 Filed Mar 5, 2018 21:52 UTC
Wolf Jacquelyn HEVP & Chief HR Officer
GrantCommon Stock 2,155 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010116 · form4.xml · nonDerivative · entry 1

Wolf Jacquelyn H · CIK 0001350861 · EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,105

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 718 shares each on 3/1/2019 and 3/1/2020, and 719 on 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:51 UTC
Samitt Craig EEVP & Chief Clinical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 11,354 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010113 · form4.xml · derivative · entry 3

Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,354

Underlying: Common Stock · 11,354 shares

Expires 2028-03-01

F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:51 UTC
Samitt Craig EEVP & Chief Clinical Officer
GrantCommon Stock 2,694 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010113 · form4.xml · nonDerivative · entry 2

Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,011

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 898 shares each on 3/1/2019, 3/1/2020 and 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:51 UTC
Samitt Craig EEVP & Chief Clinical Officer
Tax withholdingCommon Stock 677 $232.04 $157,091.08
Disclosure

SEC source: 0001127602-18-010113 · form4.xml · nonDerivative · entry 1

Samitt Craig E · CIK 0001601851 · EVP & Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,317

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:49 UTC
Penczek Ronald WSVP, Chief Accounting Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 1,634 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010108 · form4.xml · derivative · entry 5

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,634

Underlying: Common Stock · 1,634 shares

Expires 2028-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 1,634 shares, and is exercisable in six semi-annual installments, with four installments of 272 shares each and two installments of 273 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:49 UTC
Penczek Ronald WSVP, Chief Accounting Officer
GrantCommon Stock 388 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010108 · form4.xml · nonDerivative · entry 2

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,268

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 129 shares each on 3/1/2019 and 3/1/2020, and 130 on 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:49 UTC
Penczek Ronald WSVP, Chief Accounting Officer
Tax withholdingCommon Stock 125 $232.04 $29,005.00
Disclosure

SEC source: 0001127602-18-010108 · form4.xml · nonDerivative · entry 1

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 880

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:48 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
GrantEmployee Stock Option (Right to Buy) · Derivative 14,761 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010106 · form4.xml · derivative · entry 5

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,761

Underlying: Common Stock · 14,761 shares

Expires 2028-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:48 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
GrantCommon Stock 3,502 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010106 · form4.xml · nonDerivative · entry 2

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,138.1293

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:48 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
Tax withholdingCommon Stock 931 $232.04 $216,029.24
Disclosure

SEC source: 0001127602-18-010106 · form4.xml · nonDerivative · entry 1

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,636.1293

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:46 UTC
Haytaian Peter DEVP & President, GBD
GrantEmployee Stock Option (Right to Buy) · Derivative 14,761 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010102 · form4.xml · derivative · entry 6

Haytaian Peter D · CIK 0001608538 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,761

Underlying: Common Stock · 14,761 shares

Expires 2028-03-01

F5 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:46 UTC
Haytaian Peter DEVP & President, GBD
GrantCommon Stock 4,310 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 3

Haytaian Peter D · CIK 0001608538 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,653

F3 · shares: Represents restricted share units. Restrictions lapse as follows: 1,436 shares on 3/1/2019, and 1,437 shares each on 3/1/2020 and 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:46 UTC
Haytaian Peter DEVP & President, GBD
GrantCommon Stock 3,502 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 2

Haytaian Peter D · CIK 0001608538 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,343

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:46 UTC
Haytaian Peter DEVP & President, GBD
Tax withholdingCommon Stock 1,205 $232.04 $279,608.20
Disclosure

SEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,841

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:44 UTC
GRIFFIN BRIAN TEVP & President, CSBD
GrantEmployee Stock Option (Right to Buy) · Derivative 14,761 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010098 · form4.xml · derivative · entry 8

GRIFFIN BRIAN T · CIK 0001252006 · EVP & President, CSBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,761

Underlying: Common Stock · 14,761 shares

Expires 2028-03-01

F5 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:44 UTC
GRIFFIN BRIAN TEVP & President, CSBD
GrantCommon Stock 3,502 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010098 · form4.xml · nonDerivative · entry 2

GRIFFIN BRIAN T · CIK 0001252006 · EVP & President, CSBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,660

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:44 UTC
GRIFFIN BRIAN TEVP & President, CSBD
Tax withholdingCommon Stock 856 $232.04 $198,626.24
Disclosure

SEC source: 0001127602-18-010098 · form4.xml · nonDerivative · entry 1

GRIFFIN BRIAN T · CIK 0001252006 · EVP & President, CSBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,158

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:43 UTC
Gallina John EEVP & Chief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 14,761 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010095 · form4.xml · derivative · entry 5

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,761

Underlying: Common Stock · 14,761 shares

Expires 2028-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:43 UTC
Gallina John EEVP & Chief Financial Officer
GrantCommon Stock 3,502 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010095 · form4.xml · nonDerivative · entry 2

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,064

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:43 UTC
Gallina John EEVP & Chief Financial Officer
Tax withholdingCommon Stock 660 $232.04 $153,146.40
Disclosure

SEC source: 0001127602-18-010095 · form4.xml · nonDerivative · entry 1

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,562

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:41 UTC
Swedish JosephDirector · Executive Chairman
Tax withholdingCommon Stock 6,096 $232.04 $1,414,515.84
Disclosure

SEC source: 0001127602-18-010091 · form4.xml · nonDerivative · entry 1

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,447

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:38 UTC
BOUDREAUX GAILDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 46,554 $0.00 Strike: $232.04 $0.00
Disclosure

SEC source: 0001127602-18-010085 · form4.xml · derivative · entry 3

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,554

Underlying: Common Stock · 46,554 shares

Expires 2028-03-01

F2 · derivative.exercise_date: The option represents a right to purchase a total of 46,554 shares, and is exercisable in six semi-annual installments of 7,759 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.

Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:38 UTC
BOUDREAUX GAILDirector · President and CEO
GrantCommon Stock 11,044 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010085 · form4.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,044

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 3,681 shares each on 3/1/2019 and 3/1/2020, and 3,682 on 3/1/2021.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:41 UTC GrantCommon Stock 204 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-004013 · form4.xml · nonDerivative · entry 1

Jallal Bahija · CIK 0001730038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 46,600 $0.00 Strike: $89.44 $0.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · derivative · entry 10

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,600 shares

Expires 2021-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option represents a right to purchase a total of 114,100 shares, and is exercisable in six semi-annual installments, with two installments of 19,016 shares and four installments of 19,017 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 17,803 $0.00 Strike: $67.44 $0.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · derivative · entry 9

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,803 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option represents a right to purchase a total of 102,303 shares, and is exercisable in six semi-annual installments, with three installments of 17,050 shares and three installments of 17,051 shares each, beginning on October 1, 2013, which is the six-month anniversary of the option grant date.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 1,000 $247.73 $247,730.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 8

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,543

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F7 · price: This transaction was executed in multiple trades at prices ranging from $247.62 to $247.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 1,900 $246.69 $468,711.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 7

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,543

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F6 · price: This transaction was executed in multiple trades at prices ranging from $246.36 to $246.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 8,900 $245.71 $2,186,819.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 6

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,443

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F5 · price: This transaction was executed in multiple trades at prices ranging from $245.24 to $246.20. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 26,703 $244.52 $6,529,417.56
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 5

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,343

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F4 · price: This transaction was executed in multiple trades at prices ranging from $244.18 to $245.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 19,100 $243.82 $4,656,962.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 4

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,046

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F3 · price: This transaction was executed in multiple trades at prices ranging from $243.18 to $244.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 6,800 $242.40 $1,648,320.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 3

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,146

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $241.96 to $242.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionCommon Stock 46,600 $89.44 $4,167,904.00
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 2

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2018 Filed Feb 5, 2018 21:35 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionCommon Stock 17,803 $67.44 $1,200,634.32
Disclosure

SEC source: 0001127602-18-004003 · form4.xml · nonDerivative · entry 1

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 21:22 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 67,500 $0.00 Strike: $89.44 $0.00
Disclosure

SEC source: 0001127602-18-001820 · form4.xml · derivative · entry 5

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,600

Underlying: Common Stock · 67,500 shares

Expires 2021-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option represents a right to purchase a total of 114,100 shares, and is exercisable in six semi-annual installments, with two installments of 19,016 shares each and four installments of 19,017 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 21:22 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 36,858 $236.28 $8,708,808.24
Disclosure

SEC source: 0001127602-18-001820 · form4.xml · nonDerivative · entry 4

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,543

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F4 · price: This transaction was executed in multiple trades at prices ranging from $236.04 to $236.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 21:22 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 23,364 $235.58 $5,504,091.12
Disclosure

SEC source: 0001127602-18-001820 · form4.xml · nonDerivative · entry 3

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,401

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F3 · price: This transaction was executed in multiple trades at prices ranging from $235.04 to $236.03. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 21:22 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 7,278 $234.73 $1,708,364.94
Disclosure

SEC source: 0001127602-18-001820 · form4.xml · nonDerivative · entry 2

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,765

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $234.04 to $234.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 21:22 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionCommon Stock 67,500 $89.44 $6,037,200.00
Disclosure

SEC source: 0001127602-18-001820 · form4.xml · nonDerivative · entry 1

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2018 Filed Jan 8, 2018 21:18 UTC
MCCARTHY GLORIA MEVP & Chief Transformation Off
SaleCommon Stock 100 $230.08 $23,008.00
Disclosure

SEC source: 0001127602-18-001374 · form4.xml · nonDerivative · entry 2

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Transformation Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,567.1293

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2017.

Read SEC document
January 04, 2018 Filed Jan 8, 2018 21:18 UTC
MCCARTHY GLORIA MEVP & Chief Transformation Off
SaleCommon Stock 14,329 $229.68 $3,291,084.72
Disclosure

SEC source: 0001127602-18-001374 · form4.xml · nonDerivative · entry 1

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Transformation Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,667.1293

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $229.08 to $230.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 02, 2018 Filed Jan 4, 2018 21:33 UTC GrantCommon Stock 341 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-001116 · form4.xml · nonDerivative · entry 1

Neri Antonio F · CIK 0001648401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 21,125 $0.00 Strike: $67.44 $0.00
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · derivative · entry 10

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,803

Underlying: Common Stock · 21,125 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option represents a right to purchase a total of 102,303 shares, and is exercisable in six semi-annual installments, with three installments of 17,050 shares and three installments of 17,051 shares each, beginning on October 1, 2013, which is the six-month anniversary of the option grant date.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 300 $235.67 $70,701.00
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 9

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,543

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F8 · price: This transaction was executed in multiple trades at prices ranging from $235.44 to $235.78. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 800 $234.81 $187,848.00
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 8

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,843

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F7 · price: This transaction was executed in multiple trades at prices ranging from $234.39 to $235.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 800 $233.01 $186,408.00
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 7

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,643

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F6 · price: This transaction was executed in multiple trades at prices ranging from $232.86 to $233.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 5,882 $232.08 $1,365,094.56
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 6

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,443

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F5 · price: This transaction was executed in multiple trades at prices ranging from $231.75 to $232.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 7,722 $231.24 $1,785,635.28
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 5

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,325

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F4 · price: This transaction was executed in multiple trades at prices ranging from $230.75 to $231.74. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 4,321 $230.43 $995,688.03
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 4

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,047

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F3 · price: This transaction was executed in multiple trades at prices ranging from $229.75 to $230.73. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:27 UTC
Swedish JosephDirector · Executive Chairman
SaleCommon Stock 1,100 $229.13 $252,043.00
Disclosure

SEC source: 0001127602-17-033930 · form4.xml · nonDerivative · entry 3

Swedish Joseph · CIK 0001179745 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,368

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017.

F2 · price: This transaction was executed in multiple trades at prices ranging from $228.61 to $229.48. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.